Orange Book product · Generic (ANDA)
FLUCYTOSINE
FLUCYTOSINE
At a glance
Oct 17, 2017
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 17, 2017
8 yr 10 mo ago
Today
Pharmaceutical detail
Active ingredient
FLUCYTOSINE
Strength
250MG
Dosage form
CAPSULE
Route
ORAL
TE code
Not listed
Application
ANDA 206550
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of FLUCYTOSINE
- —ANCOBONBrand (NDA)
NDA 017001 · BAUSCH
- 2025FLUCYTOSINEGeneric (ANDA)
ANDA 218005 · LAURUS
- 2020FLUCYTOSINEGeneric (ANDA)
ANDA 213665 · AUROBINDO PHARMA LTD
- 2020FLUCYTOSINEGeneric (ANDA)
ANDA 212632 · STRIDES PHARMA
- 2018FLUCYTOSINEGeneric (ANDA)
ANDA 207536 · STRIDES PHARMA
- 2017FLUCYTOSINEGeneric (ANDA)
ANDA 204652 · NOVEL LABS INC
- 2011FLUCYTOSINEGeneric (ANDA)
ANDA 201566 · SIGMAPHARM LABS LLC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
